guest ::
| Home > Publications database > Clinical decision support in hematological malignancies using a case-grounded AI agent. |
| Home > Publications database > Clinical decision support in hematological malignancies using a case-grounded AI agent. |
| Journal Article | DKFZ-2026-01625 |
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
2026
Springer Nature
[New York, NY]
Abstract: Multidisciplinary tumor boards integrate longitudinal treatment histories, molecular profiling and rapidly evolving evidence to guide decisions in hematological malignancies, yet access to this level of subspecialty deliberation is increasingly uneven. Here we develop HemaGuide, a locally deployable, modular large language model agent that converts unstructured clinical documents into structured case representations, autonomously routes cases to specialized decision modes ('guideline', 'advanced' and 'molecular') and grounds recommendations in disease-specific guideline flowcharts and a clinical decision memory of >2,000 real-world tumor board cases. In expert-blinded benchmarking on 45 high-complexity cases across six foundation models, HemaGuide substantially improved concordance with tumor board decisions. A systematic ablation study across 11 layers confirmed that performance gains were routing-type-dependent, with no single component sufficient across case types. Automated classification of 70 clinically relevant missense variants showed high concordance with expert standards; no oncogenic variant was downgraded to benign and the whole workflow was completed under real-time conditions on commodity hardware with a median latency of 39 s rather than the hours typically required for manual molecular board workflows. In a simulated practice study, agent-assisted resident physicians achieved near-senior concordance and partially outperformed senior physicians in their subspecialty. External validation on 555 independent cases from a second academic center yielded 81.8% concordance across 47 entities, and a prospective 1-month silent trial on 64 consecutive, unselected cases achieved 82.8% concordance. Hallucinations occurred in 2 of 664 evaluated cases (0.3%). Together these data provide evidence that locally deployable, case-grounded large language model agents can deliver auditable clinical decision support across hematological malignancies, with concordance maintained across institutions and under real-time conditions on commodity hardware.
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; DEAL Nature ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 80 ; JCR ; Nationallizenz
; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
|
The record appears in these collections: |
